首页> 外国专利> NOVEL DHFR-DEFICIENT CHO CELL LINE TRANSFECTED BY A VECTOR WHICH OVER-EXPRESSES BCL-2 AND BECLIN-1 PROTEIN, AND A METHOD FOR PREPARATION THEREOF

NOVEL DHFR-DEFICIENT CHO CELL LINE TRANSFECTED BY A VECTOR WHICH OVER-EXPRESSES BCL-2 AND BECLIN-1 PROTEIN, AND A METHOD FOR PREPARATION THEREOF

机译:过度表达BCL-2和BECLIN-1蛋白的载体转化的新型DHFR缺失CHO细胞株及其制备方法

摘要

The present invention relates to a novel CHO cell line which is transformed to simultaneously overexpress Bcl-2, which is an anti-apoptotic gene, and Bclin-1, which is an autophagy pathway gene, and is deficient in a dihydrofolate reducatase (dhfr) gene, and to a method for producing the same. The transgenic CHO cell line of the present invention can inhibit cell death more effectively due to an autophagy induction effect resulting from the overexpression of Beclin-1, which is an autophagy pathway gene, as well as an apoptosis inhibitory effect resulting from the overexpression of Bcl-2, which is an anti-apoptotic protein. It was confirmed that the induced autophagy pathway can inhibit cell death, inhibit cell death more effectively when compared with the overexpression of only Bcl-2, which is the conventional method for inhibiting cell death, and inhibit cell death induced by stress from the external environment, and thus the novel CHO cell line can be useful in the production of therapeutic proteins.
机译:本发明涉及一种新颖的CHO细胞系,其被转化为同时过表达抗凋亡基因Bcl-2和自噬途径基因Bclin-1,并且其缺乏二氢叶酸还原酶(dhfr)。基因,以及生产该基因的方法。本发明的转基因CHO细胞系由于自噬途径基因Beclin-1的过表达引起的自噬诱导作用以及Bcl的过表达引起的凋亡抑制作用,可以更有效地抑制细胞死亡。 -2,它是一种抗凋亡蛋白。证实了诱导的自噬途径可以抑制细胞死亡,与仅Bcl-2的过表达相比可以更有效地抑制细胞死亡,Bcl-2是抑制细胞死亡的常规方法,并且可以抑制外界环境压力导致的细胞死亡,因此新的CHO细胞系可用于生产治疗性蛋白质。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号